In the rapidly evolving field of precision immunotherapy, the ability to rapidly validate targets and assess off-target toxicity is a critical bottleneck. As therapeutic discovery moves toward larger scales, the demand for high-quality, real-time data has never been higher.

At Alithea Bio, we are bridging the gap between deep learning and practical discovery. We are excited to invite you to an exclusive live demonstration of HLA-Compass, the world’s most comprehensive HLA-peptide database, to show you exactly how real-time immunopeptidomics is transforming the industry.

Why Real-Time Data Matters at Scale

Modern discovery workflows, particularly in TCR therapy and cancer vaccine development, require more than just standard predictions. To achieve high-confidence outcomes, researchers need insights into:

• Broader Allele Coverage: Expanding beyond common alleles to ensure diverse patient populations are served.

• Non-Canonical Peptides: Gaining practical insights into peptide lengths that traditional models often overlook.

• Off-Target Toxicity: Identifying potential safety risks early in the pipeline to de-risk development.

Exclusive Live Demo: HLA-Compass in Action

Join our scientific experts, Gloria Kraus (Business Development Manager) and Alisa Fuchs, PhD (Senior Bioinformatician), for a deep dive into the HLA-Compass platform.

Event Details:

• Date: Monday, March 9, 2026

• Time: 16:00 PM CET | 15:00 PM UK | 10:00 AM ET

• Format: Online Live Demo + Interactive Q&A

Who Should Attend? This session is specifically designed for professionals across the immunotherapy spectrum, including:

• Safety & Toxicology Scientists looking to improve risk assessment.

• Computational Biologists & Bioinformaticians seeking high-quality datasets for ML research.

• Cell & T-Cell Therapy Specialists focused on precise target validation.

• Vaccine Development & CDx Teams aiming to accelerate their time-to-market.

Take the Next Step in Your Discovery Journey

Don’t miss this opportunity to see how leveraging the world’s most comprehensive HLA-peptide database can improve confidence in your research and accelerate your decision-making.

Attend